Back to Search
Start Over
Restoration of mitochondria function as a target for cancer therapy.
- Source :
-
Drug discovery today [Drug Discov Today] 2015 May; Vol. 20 (5), pp. 635-43. Date of Electronic Publication: 2015 Mar 09. - Publication Year :
- 2015
-
Abstract
- Defective oxidative phosphorylation has a crucial role in the attenuation of mitochondrial function, which confers therapy resistance in cancer. Various factors, including endogenous heat shock proteins (HSPs) and exogenous agents such as dichloroacetate, restore respiratory and other physiological functions of mitochondria in cancer cells. Functional mitochondria might ultimately lead to the restoration of apoptosis in cancer cells that are refractory to current anticancer agents. Here, we summarize the key reasons contributing to mitochondria dysfunction in cancer cells and how restoration of mitochondrial function could be exploited for cancer therapeutics.<br /> (Copyright © 2015 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Antineoplastic Agents chemistry
Dichloroacetic Acid chemistry
Drug Design
Humans
Mitochondria metabolism
Mitochondria pathology
Molecular Targeted Therapy
Neoplasms metabolism
Neoplasms pathology
Oxidative Phosphorylation drug effects
Signal Transduction drug effects
Antineoplastic Agents therapeutic use
Dichloroacetic Acid therapeutic use
Energy Metabolism drug effects
Mitochondria drug effects
Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1878-5832
- Volume :
- 20
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Drug discovery today
- Publication Type :
- Academic Journal
- Accession number :
- 25766095
- Full Text :
- https://doi.org/10.1016/j.drudis.2015.03.001